Switch View
© BusinessWire
08.11.2025
ISIN: US92532F1003
Vertex Pharmaceuticals Inc
VRTX
LISTED
NASDAQ
Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week
News Preview
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced updated data for povetacicept (pove) in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) from the ongoing RUBY-3 trial at the American Society of Nephrology (ASN) Kidney Week 2025 in Houston, Texas. Pove is an investigational recombinant fusion protein therapeutic an...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Nov. 8, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US8716071076
Synopsys Inc
SNPS
LISTED
NASDAQ
ROSEN, A RANKED AND LEADING FIRM, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Synopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has alr...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
08.11.2025
ISIN: US02043Q1076
Alnylam Pharmaceuticals Inc
ALNY
LISTED
NASDAQ
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
News Preview
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic approved for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) and the polyneu...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
08.11.2025
ISIN: US12621E1038
CNO Financial Group Inc
CNO
LISTED
NYSE
Monumental Milestones at the 2025 CNO Financial Indianapolis Monumental Marathon
News Preview
INDIANAPOLIS, Nov. 8, 2025 /PRNewswire/ -- A record-breaking field of more than 17,500 runners filled the streets of downtown Indianapolis today for the 18th annual CNO Financial Indianapolis Monumental Marathon, Half Marathon and 5K. The 13th consecutive sellout of the event showcased elite performances, includi...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US45826J1051
Intellia Therapeutics Inc
NTLA
LISTED
NASDAQ
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
News Preview
CAMBRIDGE, Mass., Nov. 08, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today presented positive clinical data from a pooled analysis of all patients who received a 50 milligram (mg) dose of lonvo-z in the company...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US9897011071
Zions Bancorporation NA
ZION
LISTED
NASDAQ
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Zions Bancorporation, N.A. Investors to Inquire About Securities Class Action Investigation - ZION, ZIONP
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zions Bancorporation, N.A. (NASDAQ: ZION) (NASDAQ: ZIONP) resulting from allegations that Zions Bancorporation may have issued materially misleading busin...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 CORALreef Lipids trial demonstrating that treatment with enlicitide decanoate, an investigational, once-daily oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, resulted in a statist...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2025
ISIN: CA75585H2063
The Real Brokerage Inc.
REAX
LISTED
NASDAQ
Real Reaches Settlement in Principle in Litigation With Former CFO
News Preview
The Real Brokerage Inc. (NASDAQ: REAX), a leading real estate technology platform redefining the industry through innovation and culture, today announced that, on Nov. 5, 2025, it reached a settlement in principle in the litigation with its former Chief Financial Officer, Michelle Ressler. The court action has been dismissed by the court.
Pursua...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US3439271095
Fly-E Group, Inc.
FLYE
LISTED
NASDAQ
FLYE DEADLINE NOTICE: ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Fly-E Group, Inc. Investors to Secure Counsel Before Important November 10 Deadline in Securities Class Action - FLYE
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fly-E Group, Inc. (NASDAQ: FLYE) between July 15, 2025 and August 14, 2025, both dates inclusive (the "Class Period"), of the important November 10, 2025 lead plaintiff deadline.SO WHAT: If you p...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
News Preview
Oral presentation highlights sotagliflozin's unique benefits to HFpEF patients in significantly improving cardiac and physical performance, and quality of life Oral presentation highlights sotagliflozin's unique benefits to HFpEF patients in significantly improving cardiac and physical performance, and quality of life...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US9576381092
Western Alliance Bancorp
WAL
LISTED
NYSE
WAL Investor News: Rosen Law Firm Encourages Western Alliance Bancorporation Investors to Inquire About Securities Class Action Investigation - WAL
News Preview
NEW YORK, Nov. 8, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on beha...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
08.11.2025
ISIN: SE0002480442
Zinzino AB (B)
ZZ B
LISTED
STO
Zinzino AB (publ.): Zinzino acquires Mexican company Sanki to increase distribution capacity in North America and South America
News Preview
GOTHENBURG, Sweden, Nov. 8, 2025 /PRNewswire/ -- Zinzino has signed an agreement with Mexico-based direct sales company Sanki to acquire the rights to the company's distributor database and associated customer register, inventory, and IP rights. In addition to the assets, 100% of the shares in Sanki's subsidiarie...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2025
ISIN: US31620M1062
Fidelity National Information Services, Inc
FIS
LISTED
NYSE
FIS Launches Innovative Asset Servicing Management Suite to Unlock Operational Efficiency Across Asset Servicing
News Preview
Global financial technology leader FIS® has announced the launch of FIS Asset Servicing Management Suite, a comprehensive suite of automated and integrated solutions which help unlock operational efficiency across all areas of asset servicing.
The suite combines the traditionally separate critical functions of corporate actions processing, proxy...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US6540901096
Nidec Corporation
NJDCY
LISTED
OTC
ROSEN, LEADING INVESTOR COUNSEL, Encourages Nidec Corporation Investors to Inquire About Securities Class Action Investigation - NJDCY
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Nidec Corporation (OTC: NJDCY) resulting from allegations that Nidec Corporation may have issued materially misleading business information to the in...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US47030M1062
James Hardie Industries plc
JHX
LISTED
NYSE
JHX INVESTOR ALERT: James Hardie Industries plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
San Diego, California--(Newsfile Corp. - November 8, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of James Hardie Industries plc (NYSE: JHX) common stock (previously American Depositary Shares until their conversion to common stock on July 1, 2025) between May 20, 2025 and August 18, 2025, inclusive (the "Clas...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Important Notice to Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office Is Investigating Claims on Your Behalf
News Preview
Philadelphia, Pennsylvania--(Newsfile Corp. - November 8, 2025) - Grabar Law Office is investigating claims on behalf of Inspire Medical Systems, Inc. (NYSE: INSP) shareholders. The investigation concerns whether certain officers of Inspire Medical have breached their fiduciary duties owed to the company.Current Inspire Medical shareholders who hav...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US1431301027
Carmax Inc
KMX
LISTED
NYSE
Robbins Geller Rudman & Dowd LLP Announces that CarMax, Inc. (KMX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
SAN DIEGO, Nov. 8, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CarMax, Inc. (NYSE: KMX) publicly traded securities between June 20, 2025 and September 24, 2025, both dates inclusive (the "Class Period"), have until January 2, 2026 to seek appointment as lead...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: SE0002480442
Zinzino AB (B)
ZZ B
LISTED
STO
Zinzino AB (publ.): Zinzino acquires Mexican company Sanki to increase distribution capacity in North America and South America
News Preview
GOTHENBURG, Sweden, Nov. 8, 2025 /PRNewswire/ -- Zinzino has signed an agreement with Mexico-based direct sales company Sanki to acquire the rights to the company's distributor database and associated customer register, inventory, and IP rights. In addition to the assets, 100% of the shares in Sanki's subsidiarie...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US9290331084
Vor Biopharma Inc.
VOR
LISTED
NASDAQ
Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China
News Preview
Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction in proteinuria, with a favorable safety profile...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Clinically meaningful pivotal study results for olezarsen in sHTG presented as a late breaker at AHA Scientific Sessions
News Preview
STOCKHOLM, Nov. 8, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that, the TIMI Study Group today has presented positive results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG) at the American Heart Association 2025 Scientific Sessions. The s...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US61225M1027
Monte Rosa Therapeutics Inc
GLUE
LISTED
NASDAQ
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases
News Preview
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US87990A1060
Tenaya Therapeutics Inc
TNYA
LISTED
NASDAQ
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
News Preview
MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in Cardiovascular Research...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
News Preview
Study Also Shows 36% Reduction in Risk of Heart Attack
Repatha is the First and Only PCSK9 Inhibitor to Significantly Reduce the Risk of First Heart Attack and Stroke
THOUSAND OAKS, Calif., Nov. 8, 2025 /PRNew...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US74934Q1085
RCI Hospitality Holdings Inc
RICK
LISTED
NASDAQ
RICK Deadline: RICK Investors Have Opportunity to Lead RCI Hospitality Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
News Preview
NEW YORK, Nov. 8, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RCI Hospitality Holdings, Inc....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US0080642061
Jade Biosciences Inc
JBIO
LISTED
NASDAQ
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
News Preview
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today presented two posters for JADE101, its investigational anti-A PRoliferation-Inducing...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
News Preview
Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in patients undergoing total knee replacement...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
News Preview
- Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated:...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Groundbreaking pivotal study results of olezarsen for severe hypertriglyceridemia (sHTG) presented as a late breaker at AHA Scientific Sessions
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG). The studies met the primary endpoint, with olezarsen achieving a highly statistically significant placebo-adjusted mean reduction in fasting triglyceride (TG) le...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: CH0334081137
CRISPR Therapeutics AG
CRSP
LISTED
NASDAQ
CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering
News Preview
-Data presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions 2025-...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action - JSPR
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2025
ISIN: US68622V1061
Organon & Co
OGN
LISTED
NYSE
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities
News Preview
Organon (NYSE: OGN), a global independent healthcare company with a focus on women’s health, will present results from a sub-analysis of pooled data from the Phase 3 ADORING 1 and ADORING 2 pivotal trials evaluating VTAMA cream versus vehicle at the 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in Orla...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US08862E1091
Beyond Meat Inc
BYND
LISTED
NASDAQ
BYND SECURITIES ALERT: Beyond Meat, Inc. Investors with Losses Are Notified to Contact BFA Law About Its Pending Securities Class Action Investigation
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Beyond Meat, Inc. (NASDAQ: BYND) for potential violations of the federal securities laws. If you invested in Beyond Meat, you are encouraged to obtain additional information by visiting: https://www.b...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US47074L1052
Jamf Holding Corp
JAMF
LISTED
NASDAQ
JAMF SECURITIES NOTICE: Jamf Holding Corp. Shareholders are Notified to Contact BFA Law about its Investigation into the $13.05 Take Private Sale
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jamf Holding Corp.'s (NASDAQ: JAMF) board of directors for potential breaches of their fiduciary duties to shareholders in connection with a potential take-private sale of Jamf that would cash out ever...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX DEADLINE: MoonLake Immunotherapeutics Investors with Losses are Notified to Contact BFA Law before December 15 Securities Class Action Deadline
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are e...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US86333M1080
Stride Inc
LRN
LISTED
NYSE
LRN SECURITIES ALERT: Stride, Inc. Investors with Losses are Notified to Contact BFA Law about its Pending Securities Class Action Investigation
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Stride, Inc. (NYSE: LRN) for potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cas...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US47030M1062
James Hardie Industries plc
JHX
LISTED
NYSE
JHX DEADLINE: James Hardie Industries plc Investors with Losses are Notified to Contact BFA Law before December 23 Securities Class Action Deadline
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud after significant stock drop resulting from the potential violat...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US8716071076
Synopsys Inc
SNPS
LISTED
NASDAQ
SNPS DEADLINE: Synopsys, Inc. Investors with Losses are Notified to Contact BFA Law before December 30 Securities Class Action Deadline
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US1431301027
Carmax Inc
KMX
LISTED
NYSE
KMX DEADLINE: CarMax, Inc. Investors with Losses are Notified to Contact BFA Law before January 2 Securities Class Action Deadline
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after significant stock drop resulting from the potential violations of the fed...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DXCM DEADLINE: DexCom, Inc. Investors with Losses are Notified to Contact BFA Law before December 26 Securities Class Action Deadline
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: KYG6755S1057
OMS Energy Technologies Inc
OMSE
LISTED
NASDAQ
OMS Energy 启动 AI+ 机器人研究，进军前景广阔的输油管道检测与维护市场
News Preview
新加坡, Nov. 08, 2025 (GLOBE NEWSWIRE) -- 全球能源市场正在经历深刻变革。 在可再生能源成为各国应对气候变化的标准配置的同时，传统化石燃料也因勘探开采技术的持续创新保持稳定增长。 特别是 AI 与机器人技术的持续发展，正显著提升传统油田工程服务的成本控制、运营效率及安全水平。...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
08.11.2025
ISIN: US51654W1018
Lantern Pharma Inc.
LTRN
LISTED
NASDAQ
New to The Street to Broadcast Show Number 698 on Bloomberg - Saturday, November 8, 2025, at 6:30 PM EST
News Preview
NEW YORK CITY, NEW YORK / ACCESS Newswire / November 8, 2025 / New to The Street announces the broadcast of Show Number 698, airing on Bloomberg Television this Saturday, November 8, 2025, at 6:30 PM EST, as sponsored programming.This week's show features exclusive interviews and insights from leading companies and financial professionals:Lantern P...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US86633R6099
Datavault AI, Inc.
DVLT
LISTED
NASDAQ
Datavault AI 携手 Rodney’s Comedy Club，通过现场喜剧版权保护与行业首创的欢笑指数，为现场娱乐领域注入数字创新活力
News Preview
Datavault AI™ 将其 VerifyU 资质认证平台及 ADIO 互动技术扩展至娱乐版权与夜生活领域——这一快速发展的市场正亟需真实可靠的数字验证方案与实时数据变现技术 Datavault AI™ 将其 VerifyU 资质认证平台及 ADIO 互动技术扩展至娱乐版权与夜生活领域——这一快速发展的市场正亟需真实可靠的数字验证方案与实时数据变现技术...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk will not increase its proposal to acquire Metsera, Inc.
News Preview
Novo Nordisk today confirms that it does not intend to make an increased offer to acquire Metsera....
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US9182041080
VF Corp
VFC
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of V.F. Corporation
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In VFC To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in VFC between October 27, 2022 and May 20, 2025 a...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Cytokinetics between December 27, 2023...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US92937A1025
WPP plc
WPP
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of WPP
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In WPP To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in WPP between February 27, 2025 and July 8, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US47030M1062
James Hardie Industries plc
JHX
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of James Hardie
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In James Hardie To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in James Hardie between May 20, 2025 and...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Baxter between February 23...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US4718711033
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Jasper between November 30, 2023 and July 3,...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US7476191041
Quanex Building Products Corp
NX
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Quanex Building Products
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quanex To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Quanex between December 12, 2024 and Septemb...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US48242W1062
KBR Inc
KBR
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of KBR
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in KBR between May 6, 2025 and June 19, 2025 and w...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in aTyr between January 16, 2025 and September 12...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US86333M1080
Stride Inc
LRN
LISTED
NYSE
LRN INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner
James (Josh) Wilson
Encourages Investors Who Suffered Significant Losses In Stride To Contact Him Directly To Discuss Their Options...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Molina between February 5, 2025 and July 23,...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: GB00BMT7GT62
Marex Group PLC
MRX
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marex Group
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Marex To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Marex between May 16, 2024 and August 5, 2025 and wo...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US8716071076
Synopsys Inc
SNPS
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Synopsys
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Synopsys To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US1431301027
Carmax Inc
KMX
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CarMax
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CarMax To Contact Him Directly To Discuss Their Options
If you suffered losses in CarMax between June 20, 2025 and September 24, 2025 and would...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Lantheus between February 26, 2025 and Aug...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US9182041080
VF Corp
VFC
LISTED
NYSE
VFC DEADLINE: ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages V.F. Corporation Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action - VFC
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of V.F. Corporation (NYSE: VFC) between October 30, 2023 and May 20, 2025, both dates inclusive (the "Class Period"), of the important November 12, 2025 lead plaintiff deadline.SO WHAT: If you purch...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
